BUSINESS News

Amgen’s $27.8 Billion Deal for Horizon Therapeutics Clears Key Hurdle

HS 01/09/2023

Advertisements

The Federal Trade Commission said it had agreed to end its legal challenge of the $27.8 billion deal. The pact also dismisses the antitrust claims of six states that joined the FTC in seeking to block the transaction.

Source link

Tags: acquisitions, Acquisitions/Mergers, Acquisitions/Mergers/Shareholdings, Amgen, AMGN, Anti-Competition Issues, Biopharmaceuticals, Biotechnology Services, C&E Executive News Filter, C&E Industry News Filter, Content Types, corporate, Corporate Actions, corporate crime, Corporate Crime/Legal Action, Corporate/Industrial News, Crime, Crime/Legal Action, Eye Conditions, Factiva Filters, general news, government policy, Health, healthcare, Healthcare/Life Sciences, Horizon Therapeutics, HZNP, industrial news, legal action, life sciences, Medical Conditions, mergers, north america, Ownership Changes, Pharmaceuticals, political, Political/General News, regulation, Regulation/Government Policy, shareholdings, SYND, United States, WSJ-PRO-WSJ.com

Financial Services Roundup: Market Talk

HS 21/11/2024

Boohoo Changes Chairman as Frasers Calls For Removal

HS 21/11/2024

Resolute Mining Says CEO, Employees Released From Detention in Mali

HS 21/11/2024

Financial Services Roundup: Market Talk

HS 21/11/2024

Viral Video: US Cafe Serves Free Coffee To Anyone Who Enters While Dancing. Its A Must-Watch

HS 21/11/2024

Tesla CEO Elon Musk claims Amazon founder Jeff Bezos predicted Donald Trump's loss in US elections, Bezos replies in a rare post … – Times of India

HS 21/11/2024

AUS vs IND 1st Test, Day 1 Live Score and Reactions: India aim for early advantage in Perth

HS 21/11/2024

How To Add Pecans Into Your Favourite Indian Snacks: A Beginners Guide

HS 21/11/2024